Alternative pathway androgen biosynthesis and human fetal female virilization

Nicole Reisch,Angela E. Taylor,Edson F. Nogueira,Daniel J. Asby,Vivek Dhir,Andrew Berry,Nils Krone,Richard J. Auchus,Cedric H. L. Shackleton,Neil A. Hanley,Wiebke Arlt
DOI: https://doi.org/10.1073/pnas.1906623116
IF: 11.1
2019-10-14
Proceedings of the National Academy of Sciences
Abstract:Significance In the classic androgen biosynthesis pathway, testosterone is converted to 5α-dihydrotestosterone, a step crucially required for normal male genital virilization. Congenital adrenal hyperplasia (CAH) due to P450 oxidoreductase deficiency (PORD) is an inborn disorder that disrupts classic androgen biosynthesis. However, some affected girls present with severe genital virilization at birth. We hypothesized that this is explained by a prenatally active, alternative biosynthesis pathway to 5α-dihydrotestosterone. We show that adrenals and genital skin cooperate to produce androgens via the alternative pathway during the major period of human sexual differentiation and that neonates with PORD still produce alternative pathway androgens during the first weeks of life. This indicates that alternative pathway androgen biosynthesis drives prenatal virilization in CAH due to PORD.
What problem does this paper attempt to address?